USNA

USANA Health Sciences, Inc. NYSE

Consumer Defensive ·Packaged Foods ·US · usana.com

$18.56

Mkt Cap $342.6M

52w Low $16.60 9.0% of range 52w High $38.32

50d MA $18.63 200d MA $22.82

P/E (TTM) 33.4x

EV/EBITDA 2.4x

P/B 0.6x

Debt/Equity 0.0x

ROE 2.0%

P/FCF 42.4x

RSI (14) —

ATR (14) —

Beta 0.70

50d MA $18.63

200d MA $22.82

Avg Volume 129.3K

About

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 17, 2026	AMC	0.41	0.60	+46.3%	20.66	+9.0%	-8.0%	-0.5%	+4.9%	+5.6%	+4.8%	-17.0%	—
Oct 21, 2025	AMC	0.25	-0.15	-160.0%	21.03	+0.0%	-0.6%	-1.9%	-1.1%	-4.4%	-3.3%	-11.2%	—
Jul 22, 2025	AMC	0.54	0.74	+37.0%	31.53	+17.3%	+12.4%	+1.8%	+1.3%	-0.3%	-4.0%	-2.9%	—
Apr 22, 2025	AMC	0.70	0.73	+4.3%	24.24	+5.2%	+4.9%	+11.8%	+12.1%	+13.6%	+15.1%	+24.0%	—
Feb 25, 2025	AMC	0.49	0.64	+30.6%	31.96	+11.6%	+3.9%	-10.4%	-7.4%	-6.2%	-7.4%	-11.9%	—
Oct 22, 2024	AMC	0.49	0.56	+14.3%	34.48	-0.3%	+6.1%	+9.7%	+6.8%	+8.2%	+8.2%	+14.2%	—
Jul 23, 2024	AMC	0.65	0.54	-16.9%	45.96	-11.9%	-3.2%	-9.0%	-7.3%	-5.6%	-4.9%	-14.2%	—
Apr 30, 2024	AMC	0.69	0.86	+24.6%	41.52	+7.6%	+9.7%	+13.4%	+9.7%	+7.4%	+7.8%	+12.5%	—
Feb 6, 2024	AMC	0.52	0.87	+67.3%	47.80	+9.0%	+4.0%	+6.4%	+6.5%	+9.5%	+2.7%	+1.6%	—
Oct 24, 2023	AMC	0.64	0.59	-7.8%	55.43	-9.8%	-18.0%	-16.7%	-19.0%	-16.7%	-17.8%	-14.9%	—
Jul 25, 2023	AMC	0.70	0.89	+27.1%	63.39	+2.4%	+7.1%	+4.0%	+2.7%	+2.4%	+0.8%	+0.3%	—
Apr 25, 2023	AMC	0.77	0.95	+23.4%	62.61	+4.1%	+8.4%	+7.3%	+6.0%	+6.9%	+7.4%	-1.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 27	DA Davidson	Maintains	Neutral → Neutral	—	$33.21	$33.21	+0.0%	-13.8%	-10.9%	-9.7%	-10.9%	-7.0%
Jan 2	DA Davidson	Maintains	Neutral → Neutral	—	$35.89	$36.59	+2.0%	+1.4%	+0.8%	-2.5%	-1.6%	-2.6%
Oct 23	DA Davidson	Maintains	Neutral → Neutral	—	$34.48	$34.37	-0.3%	+6.1%	+9.7%	+6.8%	+8.2%	+8.2%
Jul 25	DA Davidson	Maintains	Neutral → Neutral	—	$44.49	$44.35	-0.3%	-6.0%	-4.2%	-2.5%	-1.7%	+0.2%
May 7	DA Davidson	Maintains	Neutral → Neutral	—	$44.61	$44.76	+0.3%	+0.3%	+0.9%	+3.8%	+4.7%	+6.0%
Feb 22	DA Davidson	Maintains	Neutral → Neutral	—	$49.30	$48.74	-1.1%	-1.8%	-1.1%	-1.6%	-2.4%	-2.5%
Oct 25	DA Davidson	Maintains	Neutral → Neutral	—	$55.43	$49.98	-9.8%	-18.0%	-16.7%	-19.0%	-16.7%	-17.8%
Apr 26	DA Davidson	Maintains	Neutral → Neutral	—	$62.61	$65.20	+4.1%	+8.4%	+7.3%	+6.0%	+6.9%	+7.4%
Feb 13	DA Davidson	Maintains	Neutral → Neutral	—	$61.13	$60.84	-0.5%	-0.0%	-0.5%	+2.0%	+1.7%	+1.9%
Oct 27	DA Davidson	Maintains	Neutral → Neutral	—	$56.84	$56.04	-1.4%	-3.2%	-2.8%	-7.6%	-5.4%	-9.9%
Jul 28	DA Davidson	Maintains	Neutral → Neutral	—	$69.42	$69.46	+0.1%	+1.1%	+0.3%	+0.8%	+0.1%	+2.0%
Jul 12	DA Davidson	Maintains	Neutral → Neutral	—	$65.94	$65.66	-0.4%	+2.3%	+2.0%	-1.2%	+1.5%	+0.4%
Jul 7	Jefferies	Downgrade	Hold → Underperform	—	$76.51	$69.00	-9.8%	-12.4%	-12.6%	-13.8%	-11.8%	-12.1%
Apr 27	DA Davidson	Maintains	Neutral → Neutral	—	$75.52	$74.78	-1.0%	+0.5%	+1.8%	+1.5%	+1.7%	+2.1%
Apr 14	DA Davidson	Maintains	Neutral → Neutral	—	$82.85	$82.93	+0.1%	-0.9%	-4.2%	-2.7%	-1.8%	-3.8%
Feb 10	Roth Capital	Maintains	Buy → Buy	—	$87.16	$95.86	+10.0%	+13.0%	+7.1%	+3.9%	+5.4%	+5.2%
Dec 17	Roth Capital	Maintains	Buy → Buy	—	$78.42	$79.47	+1.3%	-0.1%	+0.6%	-0.4%	-1.3%	+0.2%
Aug 22	Jefferies	Maintains	Hold → Hold	—	$67.49	$66.78	-1.1%	-1.7%	-4.7%	-2.9%	-3.1%	-1.8%
Jul 3	Sidoti & Co.	Downgrade	Buy → Neutral	—	$76.72	$63.39	-17.4%	-19.4%	-19.8%	-19.1%	-21.8%	-20.9%
Apr 16	Tigress Financial	Maintains	Buy → Buy	—	$84.72	$85.12	+0.5%	-0.4%	-1.7%	-2.8%	-3.5%	-2.8%
Apr 23	Pivotal Research	Downgrade	Buy → Hold	—	$100.35	$100.35	+0.0%	-4.6%	-4.3%	+6.5%	+3.8%	+5.3%
Jan 24	Sidoti & Co.	Downgrade	Buy → Neutral	—	$76.60	$75.20	-1.8%	-0.1%	-0.1%	-0.5%	-1.4%	-1.5%
May 3	Pivotal Research	Upgrade	Hold → Buy	—	$56.40	$55.95	-0.8%	+5.5%	+8.8%	+12.3%	+12.3%	+12.9%
May 1	Pivotal Research	Downgrade	Buy → Hold	—	$56.85	$56.90	+0.1%	-1.8%	-0.8%	+4.7%	+7.9%	+11.4%
Feb 10	DA Davidson	Downgrade	Buy → Neutral	—	$59.77	$48.75	-18.4%	-20.7%	-18.0%	-12.6%	-12.1%	-8.1%
Sep 16	DA Davidson	Upgrade	Neutral → Buy	—	$69.31	$70.02	+1.0%	+2.8%	+5.4%	+2.2%	+2.6%	+3.0%
Aug 6	DA Davidson	Downgrade	Buy → Neutral	—	$88.06	$86.28	-2.0%	-10.9%	-9.2%	-6.9%	-8.1%	-8.8%
Jun 26	DA Davidson	Maintains	Buy → Buy	—	$68.92	$69.50	+0.8%	+0.1%	+0.9%	-0.9%	+4.3%	+2.8%
Apr 27	Pivotal Research	Downgrade	Buy → Hold	—	$64.14	$64.11	-0.1%	-3.4%	-2.9%	-7.5%	-11.3%	-6.3%
Oct 20	Pivotal Research	Maintains	Buy → Buy	—	$40.18	$40.76	+1.4%	+2.9%	+7.0%	+7.4%	+6.2%	+6.7%
Oct 17	Canaccord Genuity	Maintains	Hold → Hold	—	$40.02	$40.51	+1.2%	+0.4%	+3.3%	+7.4%	+7.9%	+6.6%
Nov 8	Sidoti & Co.	Upgrade	Neutral → Buy	—	$33.80	$34.27	+1.4%	+4.9%	+2.7%	+1.8%	+3.1%	+1.7%
Jul 24	DA Davidson	Maintains	Neutral → Neutral	—	$40.27	$40.49	+0.5%	-8.1%	-4.1%	-2.4%	-2.0%	+1.3%
May 30	DA Davidson	Downgrade	Buy → Neutral	—	$34.73	$34.70	-0.1%	+0.7%	+0.9%	-3.1%	-4.3%	-6.5%
Feb 7	Wedbush	Upgrade	Underperform → Neutral	—	$18.96	$19.35	+2.0%	+8.3%	+7.7%	+12.8%	+11.4%	+11.7%
Dec 17	Canaccord Genuity	Downgrade	Buy → Hold	—	$19.21	$18.83	-2.0%	-0.5%	+1.6%	-3.7%	-7.6%	-11.9%
Oct 24	DA Davidson	Maintains	Buy → Buy	—	$23.48	$24.74	+5.3%	-0.6%	-6.2%	-5.8%	-8.2%	-6.5%
Oct 24	Wedbush	Maintains	Underperform → Underperform	—	$23.48	$24.74	+5.3%	-0.6%	-6.2%	-5.8%	-8.2%	-6.5%
Jul 31	Canaccord Genuity	Upgrade	Hold → Buy	—	$22.50	$22.50	+0.0%	-0.0%	-2.5%	-0.2%	+0.8%	+3.5%
Apr 24	DA Davidson	Maintains	Buy → Buy	—	$18.36	$18.27	-0.5%	+0.2%	+11.7%	+9.9%	+11.4%	+13.6%

Recent Filings

8-K · 7.01 ! Medium

USANA Health Sciences Inc -- 8-K 7.01: Regulation FD Disclosure

USANA disclosed material information via Regulation FD, signaling the company may face regulatory scrutiny or competitive pressures that could impact its direct-selling business model and revenue growth trajectory.

Feb 18

8-K · 5.02 !!! Very High

USANA Health Sciences Inc -- 8-K 5.02: Executive Change

USANA Health Sciences' CEO Jim Brown resigned, creating leadership uncertainty that could impact strategic direction and investor confidence in the direct-sales nutrition company.

Feb 11

Data updated apr 27, 2026 7:08am · Source: massive.com